MARGO KLINGENSMITH: Open Payments
NPI 1831443530 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 42 payments from 11 companies in 2025. Trend: 2023 $1,407 · 2024 $1,333 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $252 |
| Amgen Inc. | 8 | $135 |
| PFIZER INC. | 8 | $125 |
| Boston Scientific Corporation | 3 | $98 |
| Novo Nordisk Inc | 4 | $97 |
| Lilly USA, LLC | 4 | $74 |
| Medtronic, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
Products named: GEMTESA, ELIQUIS, OTEZLA, Intracept RF Probe, Rybelsus, Intracept, MOUNJARO, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
